1. Measure
- 2025 Medicare encounters with a modifier 25 office E/M and a same-day global by the same group, per rendering provider
The visit is the one you append modifier 25 to. CMS's rationale: the global package already values E/M-crosswalked pre- and post-service work, so a same-day visit duplicates payment; 50 percent matches the multiple procedure reduction [2]. Comment sought on 25 percent, inpatient E/M, and intravitreal injections such as 67028.
Visit 99212, then shaves 11300 and 11301, at 2026 non-facility RVUs [2]; the conversion factor cut comes on top.
Total non-facility RVUs, 2026 values
113011130099212Most expensive 100%, rest 50%
113011130099212CMS names otolaryngology, dermatology and podiatry, then hand surgery, physician assistants and colon and rectal surgery. Table D-B5 reflects every proposal in the rule, not the modifier 25 share alone [2].
NF = non-facility, F = facility. CMS attributes the large decreases mainly to modifier 25 and indirect practice cost index removal.
| Specialty | Typical same-day pairing | Global period |
|---|---|---|
| Dermatology | Office E/M with 11300 to 11313 shaves, 11400 to 11446 excisions, 17000 to 17111 destructions, 11102 to 11107 biopsies | 0 or 10 day |
| Otolaryngology | Office E/M with 31231 nasal endoscopy, 69210 cerumen removal, 30901 to 30903 epistaxis control | 0 day |
| Podiatry | Office E/M with 11055 to 11057 callus paring, 11719 to 11721 nail debridement, 10060 incision and drainage | 0 or 10 day |
| Orthopedics and hand surgery | Office E/M with 20600 to 20611 joint injections, 20550 to 20553 tendon injections, 29075 to 29125 casting and splinting | 0 day |
| Ophthalmology | Office E/M or eye code with 67028 intravitreal injection | 0 day |
| OB-GYN | Office E/M with 57454 to 57456 colposcopy, 58100 endometrial biopsy, 58300 IUD insertion | 0 or 10 day |
Commercial payers that follow Medicare multiple procedure logic may follow this too: a 2027 renewal question.
The specialties most exposed are the ones whose visit and procedure are the same appointment. The defense is clean modifier 25 documentation and an exposure number the board has already seen, not a rescheduled patient.
CMS proposes that when a separately identifiable office or outpatient E/M visit is furnished by the same physician or same group practice on the same day as a 0-, 10- or 90-day global procedure, the most expensive service is paid at 100 percent and all other surgical procedures or E/M visits that day at 50 percent. It is proposed for dates of service from January 1, 2027 and is not final until the CY 2027 final rule.
No. Modifier 25 still identifies a significant, separately identifiable E/M visit on the day of a procedure. The proposal changes payment for that visit when it is not the most expensive service on the date. CMS also asks for comment on whether conditions of payment should be revised to prevent scheduling services on separate days to avoid the reduction.
CMS says the modifier 25 proposal would have the largest negative impact on otolaryngology, dermatology and podiatry, and to a smaller extent hand surgery, physician assistants and colon and rectal surgery. Table D-B5 shows combined proposed impacts of -9 percent for dermatology and otolaryngology and -7 percent for orthopedic surgery, reflecting all proposals in the rule.
CMS proposed 50 percent to match the longstanding surgical multiple procedure payment reduction, and it asked for comment on whether a different value such as 25 percent would be more appropriate. The final rule will settle it.
Checked October 25, 2026. Rules change; confirm against the source before relying on them. Items marked proposed are not final until the final rule publishes.
We pull your 2025 modifier 25 and global pairs, price them under the proposal and audit the documentation behind the modifier.